Cargando…
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity
Myelofibrosis is a rare myeloproliferative disorder. The detailed descriptions of myelofibrosis in children and adolescents is limited to a few case series and case reports describing fewer than 100 patients, thus suggesting the extreme rarity of this condition prior to adulthood. Though pediatric p...
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676962/ https://www.ncbi.nlm.nih.gov/pubmed/36419910 http://dx.doi.org/10.3389/fped.2022.1031687 |